These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5961955)

  • 21. [BCG vaccination in the world].
    Toida I
    Kekkaku; 2000 Jan; 75(1):1-7. PubMed ID: 10689812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCG vaccine and isoniazid prophylaxis.
    Le CT
    Pediatrics; 1983 Sep; 72(3):439-40. PubMed ID: 6889057
    [No Abstract]   [Full Text] [Related]  

  • 23. Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature.
    Brewer TF
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S64-7. PubMed ID: 11010824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [BCG vaccine coverage in private medical practice: First data in children below two years old, seven months after the end of compulsory vaccination in France].
    Guthmann JP; de La Rocque F; Boucherat M; van Cauteren D; Fonteneau L; Lécuyer A; Cohen R; Lévy-Bruhl D
    Arch Pediatr; 2009 May; 16(5):489-95. PubMed ID: 19304464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Testing post-vaccination and post-infection hypersensitivity with the use of tuberculin PPD-S BCG Polska. I. Use of tuberculin PPD-S BCG in children vaccinated with BCG vaccine].
    Krzyszkowska A; Rzucidło L; Zelechowska M; Wasowska J; Firko-Stepniewska O; Górski S; Szumilak I
    Pneumonol Pol; 1982 Nov; 50(11):599-607. PubMed ID: 7182815
    [No Abstract]   [Full Text] [Related]  

  • 26. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
    Menzies D
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [BCG vaccination: characteristics of drugs and causes of vaccinal complications].
    Levi DT; Aksenova VA; Zakirova NR; Aleksandrova NV
    Probl Tuberk; 1999; (4):4-7. PubMed ID: 10479921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness of the specific prophylaxis of tuberculosis].
    Kasarda VV
    Probl Tuberk; 1970; 48(7):6-8. PubMed ID: 5486091
    [No Abstract]   [Full Text] [Related]  

  • 30. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Repeated tuberculin skin tests in nurse students--observation for 3 years].
    Shigetoh E; Maeda A; Oiwa H; Yokosaki Y; Murakami I
    Kekkaku; 2002 Oct; 77(10):659-64. PubMed ID: 12440140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [BCG vaccination].
    Natali F; Ramon P
    Rev Pneumol Clin; 1994; 50(5):268-74. PubMed ID: 7899761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of tuberculosis by means of living and killed].
    MAZZETTI G
    Rass Int Clin Ter; 1955 Jan; 35(2):41-9. PubMed ID: 14372168
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size?
    Tissot F; Zanetti G; Francioli P; Zellweger JP; Zysset F
    Clin Infect Dis; 2005 Jan; 40(2):211-7. PubMed ID: 15655737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical course of tuberculosis in young children, vaccinated and non-vaccinated with BCG vaccine].
    Korol OI; Odintsov AI; Krivokhizh VN
    Probl Tuberk; 1994; (6):21-4. PubMed ID: 7708640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum adenosine deaminase estimation in relation to BCG vaccination.
    Thora S; Rajsekaran P; Chhaparwal BC
    Indian Pediatr; 1995 Oct; 32(10):1087-8. PubMed ID: 8984046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vaccine prophylaxis of tuberculosis: implication and problems].
    Aksenova VA; Levi DT; Fonina EV; Vundtsettel' NN
    Probl Tuberk Bolezn Legk; 2009; (1):10-6. PubMed ID: 19253677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vaccination in the activity of the C.P.A. and its relation to current tuberculosis epidemiology].
    Giobbi A
    Lotta Tuberc; 1968; 38(1):108-10. PubMed ID: 5252501
    [No Abstract]   [Full Text] [Related]  

  • 39. [Update on the BGC vaccine. Indications for use in Europe and in developing countries].
    Guerin N; Levy-Bruhl D
    Med Trop (Mars); 1996; 56(2):173-6. PubMed ID: 8926881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mass vaccination against tuberculosis--is it necessary in Norway?].
    Eskild A
    Tidsskr Nor Laegeforen; 1994 Jun; 114(16):1840-4. PubMed ID: 8079303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.